US Patent Issued to NATIONAL UNIVERSITY CORPORATION UNIVERSITY OF TOYAMA on Aug. 4 for "Cystic lymphangioma treatment drug" (Japanese Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,324, issued on Aug. 4, was assigned to NATIONAL UNIVERSITY CORPORATION UNIVERSITY OF TOYAMA (Toyama, Japan).

"Cystic lymphangioma treatment drug" was invented by Seiji Yamamoto (Toyama, Japan), Masakiyo Sasahara (Toyama, Japan), Takeru Hamashima (Toyama, Japan) and Noriko Okuno (Toyama, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "A pharmaceutical composition for preventing or treating cystic lymphangioma comprising an agent that causes suppression of expression of amphiregulin, suppression of secretion of amphiregulin, and/or inhibition of binding of amphiregulin with an amphiregulin receptor, or an agent that causes suppression of expressio...